Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_3
3
50%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
3(50.0%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(2)
Completed(4)

Detailed Status

Completed4
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 33 (50.0%)
N/A3 (50.0%)

Trials by Status

recruiting117%
completed467%
not_yet_recruiting117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DEVICE
Total Trials
6